HomeNetherlandsGilde Healthcare Closes New Venture&Growth Fund, at €740M

Gilde Healthcare Closes New Venture&Growth Fund, at €740M

Gilde Healthcare

Gilde Healthcare, a Utrecht, The Netherlands-based healthcare investor, closed its Gilde Healthcare Venture&Growth VI fund, at €740m.

Fund VI is backed by international investors, including healthcare corporates, (Dutch) pension funds, banks, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices, entrepreneurs and the Gilde team.

The fund focuses on fast growing companies developing solutions for better care at lower cost. Gilde Healthcare invests in companies in Europe and North America active in digital healthcare, medical technology (MedTech) and therapeutics. It will invest €10-70m per new portfolio company.

Together with the previous Venture&Growth fund (closed in 2020) and Gilde Healthcare Private Equity IV (closed in 2022), Gilde Healthcare has raised €1.7 billion in capital over the last three years.

Led by Pieter van der Meer, Managing Partner, Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity.

Gilde Healthcare Venture&Growth VI is an Article 9 Fund under the Sustainable Finance Disclosure Regulation (SFDR).